C Glen Mayhall. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Cost-Benefit AnalysisCross Infection/economicsCross Infection/prevention & controlEnterococcusGram-Positive Bacterial Infections/economicsGram-Positive Bacterial Infections/prevention & controlHumansInfection Control/economicsVancomycin Resistance
Year: 2002 PMID: 12186205 DOI: 10.1086/502078
Source DB: PubMed Journal: Infect Control Hosp Epidemiol ISSN: 0899-823X Impact factor: 3.254